December 2016

Work Smarter – DAWN Version 7.9.60
Latest DAWN regional workshop – South Region
How to avoid duplicate patient records
Help & Troubleshooting Guides for your DAWN RH system
Expand your capabilities with DAWN
Children Born to Mums with Rheumatoid Arthritis at Risk for Epilepsy, Study Finds
Risk of Diabetes by Taking Antirheumatic Drugs
Methotrexate Greatly Under-prescribed for U.S. RA Patients

November 2016

4S DAWN to present at the UK Rheumatology Nurses Conference
Latest DAWN regional user group – South Region
New questionnaires to improve patient information recording and save time
Expand your capabilities with DAWN
New device approved to help rheumatology patients self-manage condition
Technology project to analyse thousands of personal experiences of rheumatoid arthritis drugs
Osteoarthritis: New blood test detects early stages, study finds

October 2016

Work Smarter – DAWN Version 7.9.59
Important Support and Troubleshooting information for your DAWN RH system
How to record visit notes in DAWN including historical cards
Expand your capabilities with DAWN
Rheumatoid Arthritis: Factors Linked With Sustained Remission Identified
Rheumatoid arthritis patients with no response to first anti-TNF more likely to respond to non-TNF biologic
Early Rheumatoid Arthritis, Bone Loss Linked to Autoantibodies

September 2016

Ad-hoc recording of outcome measures in DAWN
Use the DAWN patient view button for a concise patient summary
The importance of back ups for your DAWN system
Remember to check your Hold Monitor
Expand your capabilities with DAWN
GSK and J&J file sirukumab for rheumatoid arthritis in EU
New WHO action plan ‘will help tackle painful musculoskeletal conditions’
Patients with RA had better functional outcomes with increased adherence to treat-to-target protocol
Samsung Bioepis introduces biosimilar drug in UK

August 2016

Work smarter – Version 7.9.57
Resetting your DAWN password – help and guidance
New questionnaires to improve patient information recording and save time
Using DAWN with Internet Explorer Version 9 and 10
Increased interest in DAWN for Dermatology, Gastroenterology and Respiratory
Arthritis Research UK Musculoskeletal Health Questionnaire shows benefits in new study
Joint Surgeries Common in PsA
Rheumatoid Arthritis Patients Could Develop Second Autoimmune Condition
Heart Attack Risk for RA Patients Linked to C-Reactive Protein

July 2016

DAWN Clinical Software Workshops – Midlands and North East Regions
Checking your DAWN outbound interface
Fast and efficient electronic patient referrals
Support and trouble-shooting for your DAWN RH system and interfaces
Use of blood-based biomarker could provide early detection of response to anti-TNF treatment for RA
Rheumatoid arthritis pain ‘linked with higher chance of fatigue’
Rheumatoid arthritis effectively diagnosed and treated with biodegradable nanoparticles in early study

June 2016

DAWN Clinical Software Workshops – Midlands and North East Regions
Work Smarter – DAWN Version 7.9.55
DAWN patient View Button for a concise patient summary
Enhance your communication with timed messages from DAWN
Fast and efficient patient referrals
Support and trouble-shooting for your DAWN RH system
UK rheumatologists use factors other than NICE guidelines to treat patients with RA
There’s a cellular reason why rheumatoid arthritis may differ by location, researchers say
Biosimilars may offer hope to some RA patients, but they aren’t for everybody

May 2016

Support Desk Holiday Closures
Join us for the Latest DAWN Regional Workshops – Leicester and Newcastle
Increase Patient Engagement with the Patient Reporting Tool
Improve Clinical Outcomes with DAWN Rheumatology Software
People enduring years of pain before seeking help for arthritis
One in five rheumatoid arthritis patients missing recommended flu jab
Rheumatoid Arthritis Treatments Can Lower Cardiovascular Disease Risk, Researcher Says

April 2016

Support desk holiday closures
Visit us at the BSR Annual Conference – Stand 23
New Regional DAWN User Workshop – Midlands Region, Leicester, 28th June
The importance of upgrading your DAWN RH system
EMA Committee Backs Infliximab Biosimilar Product Flixabi
FDA Approves Inflectra for Patients with Rheumatoid Arthritis, Other Conditions
Platelet-Rich Plasma Injections Help in Knee OA

March 2016

Support desk holiday closures
Visit us at the BSR Annual Conference – Stand 23
Patient Demographics – Best Practice
5 Factors that Predict Medication Nonadherence in Patients Taking Biologics for Rheumatic Disease
Low Disease Activity Can Persist after TNF Withdrawal in Rheumatoid Arthritis
FDA Approves Once-Daily Rheumatoid Arthritis Oral Drug, Xeljanz XR

February 2016

Support desk holiday closures
Visit us at the BSR Annual Conference – Stand 23
Deceased patients – investigating Hold Monitor messages
Managing telephone calls within the DAWN system
Demographics interfacing
Early Remission Key in RA — At 2 years, half of patients were in remission, 21% were off drugs
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs
Risk of MS With TNF Inhibitor Therapy

January 2016

DAWN Messaging – Promoting effective healthcare team communication
Why results are highlighted red in the history panel
DAWN RH for scores, measures and patient reported outcomes
Increased interest in DAWN for Dermatology, Gastroenterology and Respiratory
New Classification System for SLE May Aid Earlier Diagnosis
NICE backs biosimilars in rheumatoid arthritis guidance
Anti-TNFs in RA: No Link With Stroke